{"id":"W4410811746","doi":"10.1002/jha2.70061","title":"Efficacy of Total‐Body Irradiation‐based Intensified Myeloablative Regimens for Acute Leukemia—An International Collaborative Study","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; MorphoSys; National Cancer Institute; Servier; Teijin Pharma; Otsuka Pharmaceutical; Meiji Seika Pharma; JCR Pharmaceuticals; Health Resources and Services Administration; Syndax Pharmaceuticals; Astellas Pharma; Eisai; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Omeros Corporation; Vertex Pharmaceuticals; Atara Biotherapeutics; Actinium Pharmaceuticals; Regeneron Pharmaceuticals; Medical College of Wisconsin; Pfizer; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; BeiGene; Chugai Pharmaceutical; National Marrow Donor Program; HistoGenetics; Fuji Pharma; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; Astellas Pharma US; Nippon Shinyaku; Gateway for Cancer Research; CSL Behring; Bristol-Myers Squibb; Amgen; Novartis Pharma; AbbVie; Kyowa Hakko Kirin; Sanofi","keywords":"Total body irradiation; Medicine; Internal medicine; Etoposide; Cytarabine; Hazard ratio; Hematopoietic stem cell transplantation; Cohort; Myeloid leukemia; Cyclophosphamide; Transplantation; Acute leukemia; Leukemia; Gastroenterology; Oncology; Surgery; Chemotherapy; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004905617,0.0003667884,0.0005763175,0.0008650466,0.0003220574,0.0009136008,0.0004931702,0.0002862121,0.0004960069],"category_scores_gemma":[0.004923468,0.0001560297,0.0007156183,0.001915808,0.00026478,0.0004251242,0.0004947046,0.0004546638,0.00008144986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004564834,"about_ca_system_score_gemma":0.0008344647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002947393,"about_ca_topic_score_gemma":0.004348072,"domain_scores_codex":[0.998086,0.0009591996,0.0002472518,0.0003610572,0.0002545876,0.00009190448],"domain_scores_gemma":[0.9946519,0.0009092152,0.002332316,0.0008331246,0.000738766,0.0005346058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001787954,0.0002581531,0.9842181,0.00008862528,0.001464251,0.00002280418,0.0001380356,0.0002821154,0.0003080512,0.00006145413,0.0003478872,0.01102272],"study_design_scores_gemma":[0.0005408241,0.0009206306,0.9946297,0.000067612,0.00141719,0.0001313107,0.0002239016,0.0003332083,0.0002132622,0.00003862927,0.001472099,0.00001153365],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955249,0.002119974,0.0002393667,0.00008779779,0.00001136506,0.00008153304,0.0006943262,0.000006126057,0.001234513],"genre_scores_gemma":[0.9977617,0.0005403945,0.0002541971,0.00006616674,0.00002597646,0.00004568233,0.001253129,0.000003559221,0.00004911545],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004905617,"threshold_uncertainty_score":0.02594364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02073038580851969,"score_gpt":0.3522462305389583,"score_spread":0.3315158447304385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}